Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”
Table 1
The regulators of ovotransferrin and ovotransferrin-derived peptides and adjusting effect.
Bioactive peptide
Regulated factor
The result of adjustment
Reference
IRW
Angiotensin II
Inhibited the migration of vascular smooth muscle cells
[52]
IRW
ACE inhibition and endothelial nitric oxide synthase
Antihypertensive effects
[45]
IRW and IQW
Tumor necrosis factor (TNF)
Reducing endothelial inflammation and oxidative stress
[43]
Ovotransferrin
Reactive oxygen species
Antioxidants and oxygen radical-scavenging effects
[53]
IRW
ACE2, ICAM-1, and VCAM-1
Increased ACE2 and decreased proinflammatory genes expression